157 related articles for article (PubMed ID: 32745302)
1. Botulinum toxin as a double-edged sword in alopecia: A systematic review.
Wang Y; Zhang H; Zheng Q; Tang K; Fang R; Sun Q
J Cosmet Dermatol; 2020 Oct; 19(10):2560-2565. PubMed ID: 32745302
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Glabellar Lines: A Meta-Analysis of Randomized, Placebo-Controlled, Double-Blind Trials.
Guo Y; Lu Y; Liu T; Zhou Y; Yang P; Zhu J; Chen L; Yang Q
Plast Reconstr Surg; 2015 Sep; 136(3):310e-318e. PubMed ID: 26313835
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A therapy for cervical dystonia.
Castelão M; Marques RE; Duarte GS; Rodrigues FB; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003633. PubMed ID: 29230798
[TBL] [Abstract][Full Text] [Related]
4. Is there a therapeutic effect of botulinum toxin on scalp alopecia? Physiopathology and reported cases: A systematic review of the literature.
Carloni R; Pechevy L; Postel F; Zielinski M; Gandolfi S
J Plast Reconstr Aesthet Surg; 2020 Dec; 73(12):2210-2216. PubMed ID: 32536461
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type B for cervical dystonia.
Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Intralesional Botulinum Toxin A for Treatment of Painful Cutaneous Leiomyomas: A Randomized Clinical Trial.
Naik HB; Steinberg SM; Middelton LA; Hewitt SM; Zuo RC; Linehan WM; Kong HH; Cowen EW
JAMA Dermatol; 2015 Oct; 151(10):1096-102. PubMed ID: 26244563
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial.
Attal N; de Andrade DC; Adam F; Ranoux D; Teixeira MJ; Galhardoni R; Raicher I; Üçeyler N; Sommer C; Bouhassira D
Lancet Neurol; 2016 May; 15(6):555-65. PubMed ID: 26947719
[TBL] [Abstract][Full Text] [Related]
8. Safety of botulinum toxin type A: a systematic review and meta-analysis.
Naumann M; Jankovic J
Curr Med Res Opin; 2004 Jul; 20(7):981-90. PubMed ID: 15265242
[TBL] [Abstract][Full Text] [Related]
9. Adverse Events of Botulinum Toxin Type A in Facial Rejuvenation: A Systematic Review and Meta-Analysis.
Jia Z; Lu H; Yang X; Jin X; Wu R; Zhao J; Chen L; Qi Z
Aesthetic Plast Surg; 2016 Oct; 40(5):769-77. PubMed ID: 27495260
[TBL] [Abstract][Full Text] [Related]
10. The safety and efficacy of botulinum toxin for management of scars: A systematic review with meta-analysis and trial sequential analysis.
Wang D; Qu J; Jiang H; Jiang Y
Toxicon; 2019 Aug; 166():24-33. PubMed ID: 31047933
[TBL] [Abstract][Full Text] [Related]
11. Topical calcineurin inhibitors as a double-edged sword in rosacea: A systematic review.
Zhang H; Yang L; Wang Y; Zhang D; Tang K; Fang R; Sun Q
J Cosmet Dermatol; 2022 Apr; 21(4):1695-1704. PubMed ID: 34192412
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Botulinum Toxin in Tension-Type Headaches: A Systematic Review of the Literature.
Freund B; Rao A
Pain Pract; 2019 Jun; 19(5):541-551. PubMed ID: 30742360
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.
Naumann M; Lowe NJ
BMJ; 2001 Sep; 323(7313):596-9. PubMed ID: 11557704
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin injections for adults with overactive bladder syndrome.
Duthie JB; Vincent M; Herbison GP; Wilson DI; Wilson D
Cochrane Database Syst Rev; 2011 Dec; (12):CD005493. PubMed ID: 22161392
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin for myofascial pain syndromes in adults.
Soares A; Andriolo RB; Atallah AN; da Silva EM
Cochrane Database Syst Rev; 2012 Apr; (4):CD007533. PubMed ID: 22513950
[TBL] [Abstract][Full Text] [Related]
17. Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy: A Systematic Review of Randomized Controlled Trials.
Farag SM; Mohammed MO; El-Sobky TA; ElKadery NA; ElZohiery AK
JBJS Rev; 2020 Mar; 8(3):e0119. PubMed ID: 32224633
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.
Abbott JA; Jarvis SK; Lyons SD; Thomson A; Vancaille TG
Obstet Gynecol; 2006 Oct; 108(4):915-23. PubMed ID: 17012454
[TBL] [Abstract][Full Text] [Related]
19. A Critical Review of Botulinum Toxin Type A in the Prophylactic Treatment of Chronic Migraine in Adults.
Mimeh H; Fenech Magrin AM; Myers S; Ghanem AM
Aesthet Surg J; 2019 Jul; 39(8):898-907. PubMed ID: 30184084
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin injection for chronic pelvic pain: A systematic review.
Luo FY; Nasr-Esfahani M; Jarrell J; Robert M
Acta Obstet Gynecol Scand; 2020 Dec; 99(12):1595-1602. PubMed ID: 32597494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
